A dipalmitoyl peptide that binds SH3 domain, disturbs intracellular signal transduction, and inhibits tumor growth in vivo

Ki Young Lee, Jeong Hyeok Yoon, Mihyung Kim, Sujin Roh, Yeon Sook Lee, Baik Lin Seong, Kilhyoun Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The Src homology 3 (SH3) domain plays a crucial role in protein-protein interactions during intracellular signal transduction. Blocking the SH3-mediated protein binding may inhibit the corresponding signal transduction, and thus, block the cellular functions. In this study, a peptide that specifically binds to SH3 domain could be introduced into the intracellular region when the peptides were conjugated with dipalmitic acid and appeared to disturb intracellular signaling. The dipalmitoyl peptide appeared to inhibit the phosphorylation of ZAP-70, Lck, and T-cell antigen receptor ζ in Jurkat. Mobilization of the intracellular free calcium induced by anti-CD3 antibody was reduced after treatment with the dipalmitoyl peptide. It was also observed that the dipalmitoyl peptide inhibited cancer cell growth both in vitro and in vivo. These results suggest that the dipalmitoyl peptide that presumably disturbs SH3-mediated signal transduction may have a potent anti-proliferative activity, which would be useful as a potential anti-tumor agent.

Original languageEnglish
Pages (from-to)434-442
Number of pages9
JournalBiochemical and Biophysical Research Communications
Volume296
Issue number2
DOIs
Publication statusPublished - 2002 Oct 14

Fingerprint

Src peptide
Signal transduction
src Homology Domains
Tumors
Signal Transduction
Peptides
Growth
Neoplasms
Phosphorylation
Cell growth
T-Cell Antigen Receptor
Protein Binding
Anti-Idiotypic Antibodies
Proteins

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Lee, Ki Young ; Hyeok Yoon, Jeong ; Kim, Mihyung ; Roh, Sujin ; Lee, Yeon Sook ; Seong, Baik Lin ; Kim, Kilhyoun. / A dipalmitoyl peptide that binds SH3 domain, disturbs intracellular signal transduction, and inhibits tumor growth in vivo. In: Biochemical and Biophysical Research Communications. 2002 ; Vol. 296, No. 2. pp. 434-442.
@article{a3fcb7dab54d400190b4eef22a4237a2,
title = "A dipalmitoyl peptide that binds SH3 domain, disturbs intracellular signal transduction, and inhibits tumor growth in vivo",
abstract = "The Src homology 3 (SH3) domain plays a crucial role in protein-protein interactions during intracellular signal transduction. Blocking the SH3-mediated protein binding may inhibit the corresponding signal transduction, and thus, block the cellular functions. In this study, a peptide that specifically binds to SH3 domain could be introduced into the intracellular region when the peptides were conjugated with dipalmitic acid and appeared to disturb intracellular signaling. The dipalmitoyl peptide appeared to inhibit the phosphorylation of ZAP-70, Lck, and T-cell antigen receptor ζ in Jurkat. Mobilization of the intracellular free calcium induced by anti-CD3 antibody was reduced after treatment with the dipalmitoyl peptide. It was also observed that the dipalmitoyl peptide inhibited cancer cell growth both in vitro and in vivo. These results suggest that the dipalmitoyl peptide that presumably disturbs SH3-mediated signal transduction may have a potent anti-proliferative activity, which would be useful as a potential anti-tumor agent.",
author = "Lee, {Ki Young} and {Hyeok Yoon}, Jeong and Mihyung Kim and Sujin Roh and Lee, {Yeon Sook} and Seong, {Baik Lin} and Kilhyoun Kim",
year = "2002",
month = "10",
day = "14",
doi = "10.1016/S0006-291X(02)00869-0",
language = "English",
volume = "296",
pages = "434--442",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

A dipalmitoyl peptide that binds SH3 domain, disturbs intracellular signal transduction, and inhibits tumor growth in vivo. / Lee, Ki Young; Hyeok Yoon, Jeong; Kim, Mihyung; Roh, Sujin; Lee, Yeon Sook; Seong, Baik Lin; Kim, Kilhyoun.

In: Biochemical and Biophysical Research Communications, Vol. 296, No. 2, 14.10.2002, p. 434-442.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A dipalmitoyl peptide that binds SH3 domain, disturbs intracellular signal transduction, and inhibits tumor growth in vivo

AU - Lee, Ki Young

AU - Hyeok Yoon, Jeong

AU - Kim, Mihyung

AU - Roh, Sujin

AU - Lee, Yeon Sook

AU - Seong, Baik Lin

AU - Kim, Kilhyoun

PY - 2002/10/14

Y1 - 2002/10/14

N2 - The Src homology 3 (SH3) domain plays a crucial role in protein-protein interactions during intracellular signal transduction. Blocking the SH3-mediated protein binding may inhibit the corresponding signal transduction, and thus, block the cellular functions. In this study, a peptide that specifically binds to SH3 domain could be introduced into the intracellular region when the peptides were conjugated with dipalmitic acid and appeared to disturb intracellular signaling. The dipalmitoyl peptide appeared to inhibit the phosphorylation of ZAP-70, Lck, and T-cell antigen receptor ζ in Jurkat. Mobilization of the intracellular free calcium induced by anti-CD3 antibody was reduced after treatment with the dipalmitoyl peptide. It was also observed that the dipalmitoyl peptide inhibited cancer cell growth both in vitro and in vivo. These results suggest that the dipalmitoyl peptide that presumably disturbs SH3-mediated signal transduction may have a potent anti-proliferative activity, which would be useful as a potential anti-tumor agent.

AB - The Src homology 3 (SH3) domain plays a crucial role in protein-protein interactions during intracellular signal transduction. Blocking the SH3-mediated protein binding may inhibit the corresponding signal transduction, and thus, block the cellular functions. In this study, a peptide that specifically binds to SH3 domain could be introduced into the intracellular region when the peptides were conjugated with dipalmitic acid and appeared to disturb intracellular signaling. The dipalmitoyl peptide appeared to inhibit the phosphorylation of ZAP-70, Lck, and T-cell antigen receptor ζ in Jurkat. Mobilization of the intracellular free calcium induced by anti-CD3 antibody was reduced after treatment with the dipalmitoyl peptide. It was also observed that the dipalmitoyl peptide inhibited cancer cell growth both in vitro and in vivo. These results suggest that the dipalmitoyl peptide that presumably disturbs SH3-mediated signal transduction may have a potent anti-proliferative activity, which would be useful as a potential anti-tumor agent.

UR - http://www.scopus.com/inward/record.url?scp=0036386853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036386853&partnerID=8YFLogxK

U2 - 10.1016/S0006-291X(02)00869-0

DO - 10.1016/S0006-291X(02)00869-0

M3 - Article

VL - 296

SP - 434

EP - 442

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -